DOT Expands Drug Testing to Include Semi-Synthetic Opioids
On November 13, 2017, the Department of Transportation (“DOT”) announced that it is amending its drug-testing program on January 1, 2018 to include certain semi-synthetic opioids: hydrocodone, hydromorphone, oxymorphone, and oxycodone — more commonly known as OxyContin®, Percodan®, Percocet®, Vicodin®, Lortab®, Norco®, Dilaudid®, Exalgo®. This change will require covered employers to test for a wider […]